arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Sanara MedTech Inc.

SMTI
$35.15 ▼ -0.11 (-0.31%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
59 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

Sanara MedTech Inc. faces fundamental challenges with weakness in Profit Margin (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $304.5M
Dividend Yield
Revenue Growth 8.9%
Op. Margin 6.3%
ROIC 2.6%
FCF / Share $0.23
Trailing P/E
Price / Book 40.7x
FCF Yield 0.7%
Debt / Equity 5.85
info Valuation on last close. End-of-day price, Sep 23, 2026.

59-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$28.14M
↑ +8.9%
Net Income Profit after all expenses
$-452.86K
↑ +77.5%
Operating Margin Operating profit as % of sales
6.3%
↓ -33.5% 49th
FCF / Share Free cash flow per share
$0.23
↑ +181.4%
Long-Term Debt Long-term obligations
$46.48M
↑ +0.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
29
Financial Health
29
Cash Quality
20

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 15 years · 59 quarters